BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 19295615)

  • 1. Melanoma-targeted chemo-thermo-immuno (CTI)-therapy using N-propionyl-4-S-cysteaminylphenol-magnetite nanoparticles elicits CTL response via heat shock protein-peptide complex release.
    Sato A; Tamura Y; Sato N; Yamashita T; Takada T; Sato M; Osai Y; Okura M; Ono I; Ito A; Honda H; Wakamatsu K; Ito S; Jimbow K
    Cancer Sci; 2010 Sep; 101(9):1939-46. PubMed ID: 20594194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-S-Cysteaminylphenol-loaded magnetite cationic liposomes for combination therapy of hyperthermia with chemotherapy against malignant melanoma.
    Ito A; Fujioka M; Yoshida T; Wakamatsu K; Ito S; Yamashita T; Jimbow K; Honda H
    Cancer Sci; 2007 Mar; 98(3):424-30. PubMed ID: 17270032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomechanical sensing of
    Huang PC; Chaney EJ; Aksamitiene E; Barkalifa R; Spillman DR; Bogan BJ; Boppart SA
    Theranostics; 2021; 11(12):5620-5633. PubMed ID: 33897871
    [No Abstract]   [Full Text] [Related]  

  • 4. Antitumor effects of combined therapy of recombinant heat shock protein 70 and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma.
    Ito A; Matsuoka F; Honda H; Kobayashi T
    Cancer Immunol Immunother; 2004 Jan; 53(1):26-32. PubMed ID: 14551746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor regression by combined immunotherapy and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma.
    Ito A; Tanaka K; Kondo K; Shinkai M; Honda H; Matsumoto K; Saida T; Kobayashi T
    Cancer Sci; 2003 Mar; 94(3):308-13. PubMed ID: 12824927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches.
    Hasan N; Nadaf A; Imran M; Jiba U; Sheikh A; Almalki WH; Almujri SS; Mohammed YH; Kesharwani P; Ahmad FJ
    Mol Cancer; 2023 Oct; 22(1):168. PubMed ID: 37803407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic Particle Imaging-Guided Hyperthermia for Precise Treatment of Cancer: Review, Challenges, and Prospects.
    Lei S; He J; Gao P; Wang Y; Hui H; An Y; Tian J
    Mol Imaging Biol; 2023 Dec; 25(6):1020-1033. PubMed ID: 37789103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Sulfur Containing Melanogenesis Substrate,
    Tamura Y; Ito A; Wakamatsu K; Torigoe T; Honda H; Ito S; Jimbow K
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982309
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular Events in the Melanogenesis Cascade as Novel Melanoma-Targeted Small Molecules: Principle and Development.
    Wakamatsu K; Ito A; Tamura Y; Hida T; Kamiya T; Torigoe T; Honda H; Ito S; Jimbow K
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulation of Melanoma by Chemo-Thermo-Immunotherapy Using Conjugates of Melanogenesis Substrate NPrCAP and Magnetite Nanoparticles: A Review.
    Tamura Y; Ito A; Wakamatsu K; Kamiya T; Torigoe T; Honda H; Yamashita T; Uhara H; Ito S; Jimbow K
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic Switching of B16F10 Melanoma Cells as a Stress Adaptation Response to Fe3O4/Salicylic Acid Nanoparticle Therapy.
    Mîndrilă I; Osman A; Mîndrilă B; Predoi MC; Mihaiescu DE; Buteică SA
    Pharmaceuticals (Basel); 2021 Sep; 14(10):. PubMed ID: 34681232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elucidation of Melanogenesis Cascade for Identifying Pathophysiology and Therapeutic Approach of Pigmentary Disorders and Melanoma.
    Hida T; Kamiya T; Kawakami A; Ogino J; Sohma H; Uhara H; Jimbow K
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32854423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applications of nanotechnology for melanoma treatment, diagnosis, and theranostics.
    Chen J; Shao R; Zhang XD; Chen C
    Int J Nanomedicine; 2013; 8():2677-88. PubMed ID: 23926430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanoma-Targeted Chemothermotherapy and In Situ Peptide Immunotherapy through HSP Production by Using Melanogenesis Substrate, NPrCAP, and Magnetite Nanoparticles.
    Jimbow K; Ishii-Osai Y; Ito S; Tamura Y; Ito A; Yoneta A; Kamiya T; Yamashita T; Honda H; Wakamatsu K; Murase K; Nohara S; Nakayama E; Hasegawa T; Yamamoto I; Kobayashi T
    J Skin Cancer; 2013; 2013():742925. PubMed ID: 23533767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and application of superparamagnetic iron oxide nanoparticles in targeted therapy and imaging of cancer.
    Tong L; Zhao M; Zhu S; Chen J
    Front Med; 2011 Dec; 5(4):379-87. PubMed ID: 22198749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of mouse melanoma by A/C magnetic field after delivery of bi-magnetic nanoparticles by neural progenitor cells.
    Rachakatla RS; Balivada S; Seo GM; Myers CB; Wang H; Samarakoon TN; Dani R; Pyle M; Kroh FO; Walker B; Leaym X; Koper OB; Chikan V; Bossmann SH; Tamura M; Troyer DL
    ACS Nano; 2010 Dec; 4(12):7093-104. PubMed ID: 21058696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A/C magnetic hyperthermia of melanoma mediated by iron(0)/iron oxide core/shell magnetic nanoparticles: a mouse study.
    Balivada S; Rachakatla RS; Wang H; Samarakoon TN; Dani RK; Pyle M; Kroh FO; Walker B; Leaym X; Koper OB; Tamura M; Chikan V; Bossmann SH; Troyer DL
    BMC Cancer; 2010 Mar; 10():119. PubMed ID: 20350328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth inhibition of re-challenge B16 melanoma transplant by conjugates of melanogenesis substrate and magnetite nanoparticles as the basis for developing melanoma-targeted chemo-thermo-immunotherapy.
    Takada T; Yamashita T; Sato M; Sato A; Ono I; Tamura Y; Sato N; Miyamoto A; Ito A; Honda H; Wakamatsu K; Ito S; Jimbow K
    J Biomed Biotechnol; 2009; 2009():457936. PubMed ID: 19830247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-propionyl-cysteaminylphenol-magnetite conjugate (NPrCAP/M) is a nanoparticle for the targeted growth suppression of melanoma cells.
    Sato M; Yamashita T; Ohkura M; Osai Y; Sato A; Takada T; Matsusaka H; Ono I; Tamura Y; Sato N; Sasaki Y; Ito A; Honda H; Wakamatsu K; Ito S; Jimbow K
    J Invest Dermatol; 2009 Sep; 129(9):2233-41. PubMed ID: 19295615
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.